IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novelion Therapeutics Inc

CUSIP: 67001K202 | 128 institutional holders

Quarters

Q1 2020Q4 2019Q3 2019Q2 2019Q1 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2020

Huntington National Bank300
0.0% of portfolio›$0
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Huntington National Bank
300$00.0%GrowthLowColumbus, OH2020-04-27
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2020-05-13